Angiotech Option Inferior Vena Cava Filter is Retrievable

 

June 8, 2009
The Option Inferior Vena Cava Filter. Reprinted with permission of Angiotech Pharmaceuticals.

Angiotech offers the Option Inferior Vena Cava (IVC) Filter for use in both permanent and retrievable indications for the prevention of recurrent pulmonary embolism (PE). The device is implanted, typically by interventional radiologists in a minimally invasive procedure.

In trial data, clinical success, defined as placement technical success without subsequent PE, significant filter migration or embolization, symptomatic thrombosis or other complications requiring filter removal or intervention, was achieved in 88 percent of subjects. Retrieval success was achieved in 92 percent (36/39) of cases where retrieval was attempted, with a mean implantation time in those cases of 67 days.

The Option Inferior Vena Cava Filter was approved by the FDA in June 2009.

For more information: www.angiotech.com